John Lochemes, MD
Orthopaedic Surgery · Memphis, TNNPI 1831184886
Payments from drug & device makers
Across 134 payments — averaging $44.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gentleman Orthopedic Solutions$4K
- Zyla Life Sciences, Inc.$535
- Arthrex$464
- Treace Medical Concepts, Inc.$286
- Crossroads Extremity Systems, LLC$169
- Stryker$121
- plus $416 from 8 others
What the payments were for
- Travel & lodging$1,52726%
- Food & beverage$1,97834%
- Education$2,40041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gentleman Orthopedic Solutions | 7 | $3,914 |
| Zyla Life Sciences, Inc. | 96 | $535 |
| Arthrex | 7 | $464 |
| Treace Medical Concepts, Inc. | 4 | $286 |
| Crossroads Extremity Systems, LLC | 1 | $169 |
| Stryker | 1 | $121 |
| Sanara Medtech Inc. | 1 | $93 |
| Vertex | 4 | $90 |
| Amgen(2 entities) | 6 | $88 |
| Bioventus LLC | 3 | $64 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Kerecis Limited | 1 | $21 |
| Acumed LLC | 1 | $19 |
| Medtronic | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$121
- Lapiplasty System$105
How this compares
$5,905 in reported general payments places this provider in the 55th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 35 | $1,199 |
| Diclofenac Sodium | 35 | $378 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $236 |
| Naproxen | 35 | $235 |
| Methylprednisolone | 29 | $189 |
| Gabapentin | 32 | $187 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $182 |
| Meloxicam | 46 | $144 |
| Allopurinol | 17 | $63 |
| Ondansetron Hcl | 24 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Memphis
- Michael BeebeMemphis$679K
- William FergusonMemphis$49K
- Paul BradyKnoxville$20.1M
- Jesse DotyChattanooga$2.5M
- Edwin SpencerKnoxville$2.5M
- Thomas ThrockmortonGermantown$1.9M
- Tyler BrolinCollierville$1M
- Jefferson MorrisonNashville$910K
- Matthew WillisNashville$850K
- Alton HunterColumbia$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.